Gene Query: COCH

Dataset Description Geneva Score
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 55.62
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 55.36
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 55.26
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 46.98
IL-33 activates tumor stroma to promote intestinal polyposis 46.92
RNA expression following TMPRSS11B overexpression or depletion 46.68
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 46.39
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 45.17
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 41.87
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 39.89
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 38.35
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 38.15
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 37.5
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 37.5
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 37.17
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 36.88
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 34.25
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 33.84
Global transcriptome analysis of HAP1 cells 32.03
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 31.37
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 30.3
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 29.79
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 29.42
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 28.71
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 28.67
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 26.29
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 26.29
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 26.15
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 25.21
SRSF2 mutations impair hematopoiesis and alter exon recognition 24.93
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 24.74
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 23.57
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 23.46
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 23.26
Transcriptional changes in lymphoma cells induced by LSD1 depletion 23.26
RNA-Seq from early time points in the kidney differentiation protocol 22.55
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 22.47
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 22.47
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 21.38
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 21.38
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 21.11
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 20.85
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 20.6
Gene Expression Profiling of SPOP Knocked Down Cell 20.57
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 20.2
Genome-wide chromatin analysis of Ewing sarcoma 20.2
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 20.12
Spliceosomal disruption of the non-canonical BAF complex in cancer 20.06
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 19.74
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 19.69
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 19.45
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 18.96
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 18.65
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 17.97
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 17.84
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 17.75
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 17.65
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 17.49
Mechanistic Model-Guided Study of Embryonic Morphogenesis 17.04
EP400 is required for Max and MCPyV mediated gene activation 16.83
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 16.8
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 16.8
Global gene expression profile of dasatinib-resistant RCH-ACV cells 16.54
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 16.52
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 16.38
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 16.38
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 16.2
Next Generation Sequencing of human SMA and healthy control Motor Neurons 15.82
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 15.59
An RNA-centric dissection of host complexes controlling flavivirus infection 15.59
Biological effect of chronic mistranslation in mammalian cells 15.56
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 15.43
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 15.43
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 15.21
Gene expression analysis of dengue-infected cells 15.06
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 15.05
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 14.7
Functional role of SLIT2 and ROBO1 in trophoblasts 14.7
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 14.54
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 14.48
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 14.39
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 14.39
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 14.31
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 14.22
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 14.17
Evolution of a transcriptional regulator from a transmembrane nucleoporin 14.17
RNA-seq in HepG2 and IMR90 cells 14.17
Effect of PRDM11 depletion in U2932 cells 14.09
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 14.06
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 13.99
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 13.94
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 13.93
Differential Protein Occupancy Profiling of the mRNA Transcriptome 13.81
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 13.62
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 13.61
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 13.53
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 13.51
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 13.51
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 13.38
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 13.38
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 13.36
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 13.16
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 13.1
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 12.94
The DPYSL2 gene connects mTOR and schizophrenia 12.88
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 12.84
Global analysis of alternative splicing regulated by RBM10 12.52
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 12.37
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 12.37
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 12.37
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 12.27
Ectoderm specification of H1 human embryonic stem cells 12.25
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 12.02
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 11.98
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 11.84
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 11.77
Global analyses of the effect of different cellular contexts on microRNA targeting 11.74
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 11.74
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 11.67
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 11.53
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 11.53
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 11.52
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 11.31
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 11.07
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 11.07
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 11.07
MYCi975 regulates MYC target genes 11.05
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 10.85
CD74 role in transcription regulation [RNA-seq] 10.74
CD74 role in transcription regulation 10.74
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 10.73
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 10.72
Gene expression changes after LOC550643 silencing 10.71
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 10.39
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 10.39
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 10.35
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 10.17
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 10.01
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 9.99
Epigenetic reprogramming of melanoma cells by vitamin C treatment 9.99
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 9.98
In situ CAPTURE of chromatin interactions by biotinylated dCas9 9.83
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 9.83
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 9.82
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 9.8
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 9.7
Neurofibroma 9.7
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 9.67
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 9.67
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 9.56
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 9.53
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 9.51
MEIS1 regulates hematopoiesis in hPSCs 9.49
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 9.48
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 9.37
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 9.36
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 9.25
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 9.23
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 9.23
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 9.08
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 9.08
NHLRC1 re-expression in cancer cells 9.02
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 9.0
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 8.94
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 8.94
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 8.9
Role of XRN2 ribonucleolytic activity in RNA metabolism 8.79
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 8.72
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 8.7
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 8.68
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 8.65
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 8.65
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 8.65
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 8.65
High-Throughput Kinetic Analysis of Fractional Killing 8.6
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 8.56
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 8.5
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 8.5
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 8.34
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 8.33
Global epigenomic reconfiguration during mammalian brain development 8.23
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 8.19
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 8.19
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 8.19
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 8.19
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 8.17
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 8.05
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 8.04
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 7.96
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 7.9
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 7.85
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 7.8
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 7.79
EWS-Fli and LNC regulated genes in comparison to GFP samples 7.77
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 7.71
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 7.69
Gene expression profiling of leukemia cells following asparagine depletion 7.62
A novel target of EZH1/2 for treatment of mantle cell lymphoma 7.58
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 7.56
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 7.56
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 7.54
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 7.54
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 7.53
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 7.48
The landscape of alternative splicing in aggressive prostate cancers 7.46
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 7.46
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 7.46
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 7.45
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 7.45
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 7.37
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 7.36
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 7.35
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 7.35
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 7.33
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 7.31
MYC dependent mRNA translation shapes gene expression and cell biology 7.08
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 7.08
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 7.05
RNA-seq analysis of differentiating human erythroblasts 7.02
Genome-wide discovery of human splicing branchpoints 7.01
Gene expression analysis of immortalized human liver progenitor-like cells in culture 6.93
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 6.93
Accurate annotation of human protein-coding small open reading frames 6.89
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 6.87
Lineage specific differentiation is influenced by state of human pluripotency 6.87
A transcriptome-wide divergence in protein translation scales with LIN28B expression 6.83
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 6.81
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 6.81
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 6.81
Differential gene expression profiles in imatinib-resistant cell lines 6.81
RNA-seq in endometrial stromal tumors 6.8
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 6.79
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 6.79
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 6.77
Co-regulation of splicing by Rbfox1 and hnRNP M 6.77
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 6.74
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 6.74
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 6.73
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 6.68
iPSC-Derived Cholangiocytes 6.62
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 6.61
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 6.59
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 6.55
Fibroblasts in cholesteatoma activate osteoclasts. 6.45
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 6.44
METTL3 and WTAP 6.39
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 6.38
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 6.37
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 6.36
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 6.35
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 6.35
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 6.32
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 6.3
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 6.27
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 6.26
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 6.26
Non-coding regions are the main source of tumor-specific antigens 6.24
Non-coding regions are the main source of tumor-specific antigens [human] 6.24
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 6.2
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 6.16
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 6.15
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 6.15
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 6.05
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 6.05
TGF-β promotes genomic instability after loss of RUNX3 6.04
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 5.98
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 5.97
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 5.94
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 5.93
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 5.92
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 5.9
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 5.9
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 5.89
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 5.87
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 5.86
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 5.85
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 5.81
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 5.81
Transcriptome analysis upon C6orf203 silencing 5.79
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 5.74
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 5.74
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 5.72
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 5.71
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 5.67
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 5.61
N6-methyladenine DNA Modification in Glioblastoma 5.59
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 5.59
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 5.58
RNA-seq analysis of AML cells in response to ASLAN003 5.58
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 5.54
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 5.52
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 5.52
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 5.47
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 5.44
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 5.43
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 5.43
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 5.39
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 5.38
SETBP1-WT and SETBP1-G870S epigenetic landscapes 5.37
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 5.37
Genome-wide discovery of human splicing branchpoints [RNAse] 5.32
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 5.23
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 5.23
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 5.22
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 5.18
TAF1 is critical for AE driven leukemogenesis 5.18
Profiling of escape kinetics of viruses subjected to RNAi 5.17
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 5.15
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 5.08
Transcriptome of EBV-infected gastric cancer cell lines 5.06
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 5.05
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 5.05
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 5.04
Mapping interactions for the TNIP2 hub protein 5.01
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 4.97
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 4.96
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 4.96
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 4.9
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 4.84
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 4.82
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 4.75
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 4.74
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 4.74
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 4.72
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 4.7
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 4.7
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 4.55
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 4.54
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 4.51
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 4.51
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 4.49
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 4.49
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 4.31
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 4.27
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 4.27
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 4.18
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 4.16
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 4.09
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 4.08
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 4.02
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 3.98
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 3.89
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 3.87
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 3.87
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 3.87
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 3.84
RNA sequencing of human pancreatic cancer cell lines 3.78
Ribosomal protein RPL26 is the principal target of UFMylation 3.73
Total RNA-Seq data from leukemic patients with complex structural variants 3.72
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.65
Loss of CREBBP results in gene expression repression in lymphoma cells 3.65
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 3.65
RNA seq comparison between scrambled and shGRP78 cells 3.64
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 3.58
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 3.58
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.56
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 3.56
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 3.55
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 3.55
Effect of disulfiram treatment on pediatric high grade glioma 3.52
mRNA sequencing of oropharyngeal cancer cell lines 3.41
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 3.32
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 3.32
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 3.32
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 3.25
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 3.23
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 3.15
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 3.12
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 3.08
The effect of insulin on mRNA transcription of human pluripotent stem cells 3.04
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 2.99
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 2.98
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 2.97
Identification of a LIF-responsive replication-competent human β cell 2.93
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 2.91
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 2.91
SOX11 knockdown in B-ALL cell lines 2.9
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 2.89
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 2.89
K562 polyA RNA-Seq 2.88
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 2.71
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 2.61
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 2.61
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 2.57
The Genetic Landscape of Diamond-Blackfan Anemia 2.56
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 2.55
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 2.51
Epigenomic conservation of transposable element silencing 2.5
Epigenomic conservation of transposable element silencing [RNA-seq] 2.5
BACH2 in human plasma cell fate decision 2.5
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.44
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 2.37
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 2.34
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 2.34
The pause-initiation limit restricts transcription activation in human cells 2.32
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 2.23
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 2.18
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 2.18
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 2.18
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.14
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.14
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 2.11
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 2.1
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 2.1
Gene profiling of human adult and pediatric liver cancer cells 1.99
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 1.98
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.97
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 1.93
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 1.93
FOXP2's impact on the primate transcriptome 1.88
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 1.82
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.82
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 1.76
Zika virus infection reprograms global transcription of host cells to allow sustained infection 1.72
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 1.72
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.72
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 1.66
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.6
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.6
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 1.59
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 1.59
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.47
MHC Transcriptomic landscape at haplotype-specific resolution 1.43
HEK293 TFAM Knockout Expression Study 1.42
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.38
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 1.37
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.35
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.35
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 1.33
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 1.29
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 1.26
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 1.25
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 1.25
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.25
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 1.19
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 1.19
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 1.18
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 1.18
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 1.17
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 1.15
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.14
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 1.13
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 1.13
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.11
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 1.11
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 1.05
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 1.05
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.02
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.98
Leucegene: AML sequencing (part 6) 0.97
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 0.9
A549 cell transcriptome responses to infection with H7N9 influenza virus 0.84
JAK dependent survival of ALK- ALCL 0.83
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.79
Human islets of varying quality: the good, the (not so) bad and the ugly 0.74
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.73
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.73
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 0.72
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 0.69
Primate transcript and protein expression levels evolve under compensatory selection pressures 0.67
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.66
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 0.65
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 0.65
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.61
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 0.58
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.56
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.55
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.54
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.54
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.54
Specific molecular signatures underlie response to decitabine in CMML 0.52
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.52
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.47
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.45
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.44
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.44
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.43
Oncogenic roles of ARID5B in T-ALL 0.43
Function and hormonal regulation of GATA3 in human first trimester placentation 0.42
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 0.38
ML29755 RNA-seq data 0.35
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 0.35
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 0.31
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 0.28
Transcriptome sequencing of K-562 cells 0.26
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.23
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 0.22
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.21
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 0.2
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.17
Effect of nuclear IL-33 on gene expression 0.16
hNSCs siRNA NOVA2 0.16
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 0.15
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 0.13
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.11
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.11
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.08
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 0.05
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.02
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation